These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 26258407

  • 1. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
    Chung S, Dwabe S, Elshimali Y, Sukhija H, Aroh C, Vadgama JV.
    PLoS One; 2015; 10(8):e0134948. PubMed ID: 26258407
    [Abstract] [Full Text] [Related]

  • 2. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
    Abajo A, Bitarte N, Zarate R, Boni V, Lopez I, Gonzalez-Huarriz M, Rodriguez J, Bandres E, Garcia-Foncillas J.
    World J Gastroenterol; 2012 Feb 21; 18(7):637-45. PubMed ID: 22363134
    [Abstract] [Full Text] [Related]

  • 3. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H, Yin H, Yan S, Tao M, Xie Y, Chen W.
    Oncol Rep; 2016 May 21; 35(5):2927-35. PubMed ID: 26936485
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H, Ren G, Wang T, Chen Y, Gong C, Bai Y, Wang B, Qi H, Shen J, Zhu L, Qian C, Lai M, Shao J.
    Carcinogenesis; 2015 Apr 21; 36(4):459-68. PubMed ID: 25750173
    [Abstract] [Full Text] [Related]

  • 6. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4.
    Yang L, Hu S, Tan J, Zhang X, Yuan W, Wang Q, Xu L, Liu J, Liu Z, Jia Y, Huang X.
    Oncotarget; 2016 Sep 20; 7(38):61562-61574. PubMed ID: 27528036
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer.
    Wang Y, Sun N, Lu C, Bei Y, Qian R, Hua L.
    Int J Oncol; 2017 Jun 20; 50(6):2191-2199. PubMed ID: 28498393
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K, Toiyama Y, Tanaka K, Saigusa S, Hiro J, Uchida K, Inoue Y, Kusunoki M.
    Ann Surg Oncol; 2012 Jul 20; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Zipin-Roitman A, Meshel T, Sagi-Assif O, Shalmon B, Avivi C, Pfeffer RM, Witz IP, Ben-Baruch A.
    Cancer Res; 2007 Apr 01; 67(7):3396-405. PubMed ID: 17409450
    [Abstract] [Full Text] [Related]

  • 14. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
    Kuo LJ, Hung CS, Chen WY, Chang YJ, Wei PL.
    J Surg Res; 2013 Nov 01; 185(1):264-72. PubMed ID: 23759331
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.
    Hur K.
    BMB Rep; 2015 Apr 01; 48(4):217-22. PubMed ID: 25603797
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance.
    Luo F, Li J, Wu S, Wu X, Chen M, Zhong X, Liu K.
    Oncotarget; 2016 Sep 27; 7(39):63937-63949. PubMed ID: 27613840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.